Guang Wang Selected Research

senkyunolide H

4/2022

Senkyunolide H inhibits activation of microglia and attenuates lipopolysaccharide-mediated neuroinflammation and oxidative stress in BV2 microglia cells via regulating ERK and NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang Wang Research Topics

Disease

33	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2005
30	Insulin Resistance 03/2022 - 05/2005
21	Inflammation (Inflammations) 01/2021 - 01/2008
16	Neoplasms (Cancer) 02/2022 - 09/2011
13	Obesity 05/2022 - 01/2014
12	Hypothyroidism 05/2021 - 01/2015
9	Overweight 05/2022 - 01/2014
7	Hyperhomocysteinemia 12/2021 - 04/2005
7	Body Weight (Weight, Body) 01/2021 - 07/2012
6	Non-alcoholic Fatty Liver Disease 04/2021 - 03/2015
6	Atherosclerosis 07/2019 - 11/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2016
5	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2014
5	Neural Tube Defects (Exencephaly) 06/2021 - 01/2013
5	Dysbiosis 01/2021 - 01/2018
5	Wounds and Injuries (Trauma) 01/2021 - 01/2009
5	Fibrosis (Cirrhosis) 01/2021 - 02/2016
5	Hypertriglyceridemia 05/2020 - 06/2013
5	Burns 06/2013 - 10/2007
4	Hypoxia (Hypoxemia) 01/2022 - 05/2016
4	Thyroiditis 11/2020 - 01/2017
4	Glucose Intolerance 11/2019 - 01/2013
3	Infections 05/2022 - 01/2019
3	Stroke (Strokes) 05/2022 - 01/2021
3	Kidney Calculi (Kidney Stone) 05/2022 - 01/2021
3	Weight Loss (Weight Reduction) 01/2022 - 01/2021
3	Shellfish Poisoning 06/2021 - 07/2017
3	Myocardial Infarction 01/2021 - 11/2004
3	Hypertension (High Blood Pressure) 01/2021 - 12/2003
3	Diabetes Mellitus 01/2021 - 10/2016
3	Fatty Liver 01/2021 - 03/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 11/2020
3	Ovarian Epithelial Carcinoma 11/2020 - 02/2015
3	Hyperglycemia 01/2020 - 01/2018
3	Graves Disease (Basedow Disease) 01/2020 - 01/2017
3	Hypertrophy 01/2019 - 01/2015
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018 - 01/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 05/2005
2	Necrosis 05/2022 - 07/2012

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 05/2005
15	HomocysteineIBA 01/2022 - 11/2004
12	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2014
11	Pharmaceutical PreparationsIBA 02/2022 - 12/2003
10	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 06/2016
9	CholesterolIBA 02/2022 - 10/2014
8	LipopolysaccharidesIBA 04/2022 - 04/2005
8	Therapeutic UsesIBA 01/2022 - 03/2003
8	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 01/2011
7	LipidsIBA 03/2022 - 12/2018
7	CreatinineIBA 01/2022 - 07/2008
7	Triglycerides (Triacylglycerol)IBA 07/2021 - 11/2016
7	HDL CholesterolIBA 04/2021 - 06/2013
7	Blood Glucose (Blood Sugar)IBA 12/2018 - 08/2012
6	Exenatide (Byetta)FDA Link 01/2022 - 06/2016
6	Acarbose FDA LinkGeneric 01/2022 - 01/2014
6	C-Reactive ProteinIBA 04/2021 - 10/2007
6	LDL CholesterolIBA 04/2021 - 06/2013
6	Insulin (Novolin)FDA Link 01/2021 - 05/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
5	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022 - 04/2019
5	ChemokinesIBA 01/2022 - 04/2005
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2015
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 06/2013
5	oxidized low density lipoproteinIBA 01/2020 - 06/2013
5	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2013
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2008
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2021 - 04/2016
4	fibroblast growth factor 21IBA 01/2021 - 03/2015
4	SaltsIBA 01/2021 - 07/2015
4	baicalinIBA 01/2021 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2020 - 02/2016
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 05/2015
4	Alanine Transaminase (SGPT)IBA 08/2017 - 07/2008
3	Biological ProductsIBA 01/2022 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2005
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	AlbuminsIBA 01/2022 - 04/2016
3	Okadaic AcidIBA 06/2021 - 07/2017
3	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 06/2014
3	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2015
3	Messenger RNA (mRNA)IBA 01/2021 - 07/2015
3	AntibodiesIBA 11/2020 - 09/2020
3	PlatinumIBA 11/2020 - 02/2015
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2020 - 01/2020
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 12/2018
3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 02/2015
3	Cadherins (E-Cadherin)IBA 01/2019 - 09/2013
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2017 - 07/2008
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2016 - 07/2015
3	Urea (Carbamide)FDA LinkGeneric 06/2013 - 07/2008
3	NitrogenIBA 06/2013 - 07/2008
3	PPAR-gamma AgonistsIBA 01/2008 - 05/2005
3	Rosiglitazone (Avandia)FDA Link 01/2008 - 05/2005
2	InflammasomesIBA 05/2022 - 01/2021
2	NLR ProteinsIBA 05/2022 - 01/2021
2	Blood Proteins (Serum Proteins)IBA 05/2022 - 01/2019

Therapy/Procedure

25	Therapeutics 02/2022 - 11/2008
4	Drug Therapy (Chemotherapy) 11/2020 - 01/2009
3	Glycemic Control 01/2022 - 01/2017
3	Percutaneous Coronary Intervention 01/2008 - 11/2004